A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment
about
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systemsBlockade of muscarinic receptors impairs the retrieval of well-trained memory.D-cycloserine in prelimbic cortex reverses scopolamine-induced deficits in olfactory memory in rats.The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.Performance of conventional pigs and Göttingen miniature pigs in a spatial holeboard task: effects of the putative muscarinic cognition impairer Biperiden.Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine.A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders.Loss of M1 Receptor Dependent Cholinergic Excitation Contributes to mPFC Deactivation in Neuropathic Pain.Working memory in the odor span task: effects of chlordiazepoxide, dizocilpine (MK801), morphine, and scopolamine.Auraptene consolidates memory, reverses scopolamine-disrupted memory in passive avoidance task, and ameliorates retention deficits in mice.Drugs Interfering with Muscarinic Acetylcholine Receptors and Their Effects on Place Navigation.Cognition Enhancing and Neuromodulatory Propensity of Bacopa monniera Extract Against Scopolamine Induced Cognitive Impairments in Rat Hippocampus.Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram.Neuromodulatory propensity of Bacopa monniera against scopolamine-induced cytotoxicity in PC12 cells via down-regulation of AChE and up-regulation of BDNF and muscarnic-1 receptor expression.5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice.Cognitive Disorders: Impairment, Aging, and Dementia
P2860
Q28481245-B0334AF8-31FD-430E-8262-C2110C09B5A0Q30576082-E70454B0-72E3-4DEF-B492-92BD9776C99EQ34926000-A3EEA222-5FEE-4064-9D74-5DB17D27CFFEQ35689769-1E6B7796-ABE6-4318-BBF6-D0A7316BE28EQ36585301-0383FC28-CA29-478B-B56D-7EAB69627F9CQ37297958-06FABA71-D3EC-4682-8369-39178F7BCD81Q38851564-383B78E6-ECD6-4435-B23A-5845902A013FQ42315874-F06C00C7-B5D4-4C19-84AA-17D87A0E8AA0Q42427782-82429197-8254-4F0E-8B45-7BB82D71D59AQ43095857-B3392E0F-42DA-4510-8F49-E97A5BFFECCBQ44073064-D884418E-1514-48A4-BA9F-FD2D655396FEQ47587937-DDDC3504-75BB-4757-B99D-448C353ADCFBQ50608286-0F876528-7C77-465A-B9AE-B0715048CE13Q50860319-DA3D9D38-8746-464D-8D71-1F43B75A39A1Q50965059-FF117529-651A-4EA7-B0EA-C5EF551531F1Q55178268-E654B7D0-CAFE-4C63-972D-5B8537CE01F9
P2860
A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A comparison of scopolamine an ...... olinergic cognitive impairment
@ast
A comparison of scopolamine an ...... olinergic cognitive impairment
@en
type
label
A comparison of scopolamine an ...... olinergic cognitive impairment
@ast
A comparison of scopolamine an ...... olinergic cognitive impairment
@en
prefLabel
A comparison of scopolamine an ...... olinergic cognitive impairment
@ast
A comparison of scopolamine an ...... olinergic cognitive impairment
@en
P2860
P1433
P1476
A comparison of scopolamine an ...... olinergic cognitive impairment
@en
P2093
Arjan Blokland
Inge Klinkenberg
P2860
P2888
P304
P356
10.1007/S00213-011-2171-1
P577
2011-02-19T00:00:00Z
P5875
P6179
1012143613